Answers are grounded in this paper and cite their sources.
BACKGROUND: Early identification of newborns with mild encephalopathy at risk of clinical progression is critical. Our group has previously demonstrated regional quantification of oxygen extraction fraction (OEF), a noninvasive MRI-derived measure of cerebral oxygen utilization in newborns with encephalopathy receiving therapeutic hypothermia (TH). This study evaluates whether regional OEF measured between 2 and 7 days of life distinguishes newborns with mild encephalopathy who are not treated with TH and subsequently exhibit clinical progression within the first day of life from those who remain clinically stable. OEF was quantified across six predefined venous drainage regions. RESULTS: Fifty-three full-term newborns (28 with mild encephalopathy, 25 healthy controls) were enrolled. Seven newborns with mild encephalopathy showed clinical progression on the first day of life and received TH (TH group); the remaining did not receive TH (non-TH group). OEF was significantly lower in cortical regions in the TH group compared with healthy controls and the non-TH group. CONCLUSION: Cortical OEF represents an innovative imaging biomarker. Prospective studies are needed to determine its value for risk stratification during the therapeutic window. IMPACT: Early identification of newborns with mild encephalopathy at risk of progression remains challenging during the therapeutic window. Cortical oxygen extraction fraction (OEF) measured between 2 and 7 days of life was significantly lower in newborns who progressed within the first day of life than in newborns with mild encephalopathy who did not progress and healthy controls. Regional OEF may provide a noninvasive biomarker for early risk stratification and treatment decision-making in newborns with mild encephalopathy.
No takes yet. Share an insight, caveat, or question.
Kota et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: